JY
IMCR icon

Jeff Yass’s Immunocore IMCR Stock Holding History

Jeff Yass’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
34,170
+25,548
+296% +$756K ﹤0.01% 7995
2026
Q1 		$260K Sell
8,622
-26,566
-75% -$859K ﹤0.01% 11178
2025
Q4 		$1.22M Buy
35,188
+24,995
+245% +$882K ﹤0.01% 6727
2025
Q3 		$370K Buy
10,193
+1,299
+15% +$44.1K ﹤0.01% 9638
2025
Q2 		$279K Buy
+8,894
New +$276K ﹤0.01% 10511
2024
Q4 		– Sell
-112,199
Closed -$3.55M – 12670
2024
Q3 		$3.49M Buy
+112,199
New +$4.08M ﹤0.01% 4266
2023
Q4 		– Sell
-4,386
Closed -$228K – 12796
2023
Q3 		$228K Buy
+4,386
New +$260K ﹤0.01% 9944
2023
Q2 		– Sell
-19,727
Closed -$1.13M – 12572
2023
Q1 		$975K Sell
19,727
-1,608
-8% -$90.4K ﹤0.01% 6883
2022
Q4 		$1.22M Sell
21,335
-21,243
-50% -$1.2M ﹤0.01% 5761
2022
Q3 		$2M Sell
42,578
-14,831
-26% -$707K ﹤0.01% 4932
2022
Q2 		$2.14M Buy
+57,409
New +$1.86M ﹤0.01% 4769

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jeff Yass's IMCR Position: Q2 2026 in Review

Jeff Yass increased its Immunocore (IMCR) stake by 296% in Q2 2026, buying an estimated $756K and bringing the position to 34,170 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #7995.

Jeff Yass first reported a position in IMCR in Q2 2022 and has held it in 11 quarters since. The position peaked at $3.49M in Q3 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Jeff Yass held 34,170 shares of Immunocore worth $1.08M as of Q2 2026.
  • Jeff Yass bought 25,548 Immunocore shares in Q2 2026, an estimated $756K.
  • Immunocore made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7995 holding.
  • Jeff Yass first reported a position in Immunocore in Q2 2022 and has held it in 11 quarters since.
  • Jeff Yass's Immunocore position peaked at $3.49M in Q3 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.